Stock Scorer

agilon health, inc. (AGL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 600M 1.2B 1.8B Q3 '21: 458.6M Q4 '21: 150.8M Q1 '22: 653.4M Q2 '22: 670.1M Q3 '22: 694.9M Q4 '22: 369.8M Q1 '23: 1.1B Q2 '23: 1.1B Q3 '23: 1.1B Q4 '23: 1.1B Q1 '24: 1.6B Q2 '24: 1.5B Q3 '24: 1.5B Q4 '24: 1.5B Q1 '25: 1.5B Q2 '25: 1.4B Q3 '25: 1.4B Q4 '25: 1.6B Q1 '26: 1.4B Q2 '26: 1.5B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-210M -140M -70M 0 70M 140M 210M Q3 '21: -35.6M Q4 '21: -26.2M Q1 '22: -743K Q2 '22: -21.1M Q3 '22: -29.5M Q4 '22: -54.1M Q1 '23: 417K Q2 '23: -29M Q3 '23: -39.3M Q4 '23: -164.3M Q1 '24: -7.2M Q2 '24: -43.3M Q3 '24: -133.5M Q4 '24: -108.1M Q1 '25: -22.1M Q2 '25: -116M Q3 '25: -131.3M Q4 '25: -193.8M Q1 '26: 4M Q2 '26: 11.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-240M -160M -80M 0 80M 160M 240M Q3 '21: -35.8M Q4 '21: -56.7M Q1 '22: 1.2M Q2 '22: -20.6M Q3 '22: -30.7M Q4 '22: -56.5M Q1 '23: 16M Q2 '23: -16.7M Q3 '23: -31.4M Q4 '23: -230.4M Q1 '24: -6.1M Q2 '24: -30.7M Q3 '24: -117.6M Q4 '24: -105.8M Q1 '25: 12.1M Q2 '25: -104.4M Q3 '25: -110.2M Q4 '25: -188.9M Q1 '26: 48.9M Q2 '26: 18M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '21: -19.1M Q4 '21: -48.9M Q1 '22: -23.2M Q2 '22: -60.3M Q3 '22: 2.6M Q4 '22: -50M Q1 '23: -60.8M Q2 '23: -21.2M Q3 '23: -13M Q4 '23: -61.2M Q1 '24: -47.8M Q2 '24: -18.7M Q3 '24: -7.7M Q4 '24: 16.4M Q1 '25: -32M Q2 '25: -35.1M Q3 '25: -18.2M Q4 '25: -20.5M Q1 '26: 23.7M Q2 '26: -57.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '21: -21.7M Q4 '21: -52.3M Q1 '22: -27.3M Q2 '22: -64.7M Q3 '22: -786K Q4 '22: -53.4M Q1 '23: -64.5M Q2 '23: -25.3M Q3 '23: -17.1M Q4 '23: -65.1M Q1 '24: -50.9M Q2 '24: -22M Q3 '24: -11.2M Q4 '24: 13.2M Q1 '25: -35.8M Q2 '25: -38.3M Q3 '25: -21.3M Q4 '25: -23.5M Q1 '26: 20.6M Q2 '26: -60.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '21: 325.7M Q2 '21: 377.4M Q3 '21: 391.2M Q1 '22: 424.1M Q2 '22: 407.3M Q3 '22: 411.1M Q1 '23: 426.6M Q2 '23: 410.3M Q3 '23: 405.8M Q1 '24: 408.9M Q2 '24: 411.3M Q3 '24: 411.6M Q1 '25: 16.5M Q2 '25: 16.6M Q3 '25: 414.5M Q1 '26: 16.7M Q2 '26: 17.2M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

Not drawn for AGL: Gross Profit, Cost of Revenue, EPS. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.